Skip to main content
Equibles
EMBC logo

EMBC · Embecta Corp.

Track EMBC — free

Use EMBC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$5.80 +0.11 (+1.93%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$328.63M
Shares
56.66M

EMBC metrics

93 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.80
Market cap
$328.63M

Price action

19 metrics
Price change (1W)
+14.9%
Price change (30D)
+16.2%
Price change (3M)
+71.6%
Price change (6M)
-36.1%
Price change (YTD)
-51.2%
Price change (1Y)
-60.0%
Trailing year
Price change (5Y)
—
52-week high
$15.31
52-week low
$2.90
Change from 52-week high
-62.1%
Change from 52-week low
+100.0%
Annualized volatility
80.2%
Beta
0.4
RSI (14D)
74.8
Price vs SMA 50
+40.4%
Price vs SMA 200
-24.7%
Avg volume (3M)
1.84M
Relative volume
0.5
Average dollar volume
$7.10M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
56.66M

Valuation

12 metrics
P / E (TTM)
3.9
Trailing earnings · reciprocal yield 25.3%
PEG ratio
—
EV / revenue
1.5×
reciprocal yield 64.9%
EV / EBITDA
5.9×
reciprocal yield 17.1%
EV / EBIT
7.0×
reciprocal yield 14.2%
P / sales
0.3×
reciprocal yield 310.0%
P / book
—
FCF yield
50.1%
TTM · current market cap
Buyback yield
—
P / FCF
2.0
reciprocal yield 50.1%
P / operating cash flow
1.9
reciprocal yield 53.0%
Earnings yield
26.6%

Historical valuation

8 metrics
P / E historical average (3Y)
12.0×
reciprocal yield 8.3%
P / E historical average (5Y)
12.4×
reciprocal yield 8.1%
EV / revenue historical average (3Y)
1.9×
reciprocal yield 53.2%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 49.4%
EV / EBIT historical average (3Y)
10.8×
reciprocal yield 9.3%
EV / EBIT historical average (5Y)
10.8×
reciprocal yield 9.3%
EV / EBITDA historical average (3Y)
8.9×
reciprocal yield 11.2%
EV / EBITDA historical average (5Y)
9.2×
reciprocal yield 10.9%

Dividends & buybacks

7 metrics
Dividend yield
5.5%
Trailing 12 months
Payout ratio
31.1%
Shareholder yield
8.3%
Dividend / share (TTM)
$0.32
Dividend growth YoY
-46.7%
Dividend growth streak
—
Last ex-dividend
2026-08-27

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
59.0%
Operating margin
21.9%
Trailing 12 months
Net margin
8.6%
Gross profit (TTM)
$601.30M
Operating profit (TTM)
$223.50M
Net income (TTM)
$87.50M
Trailing 12 months
Diluted EPS (TTM)
$1.47
FCF margin
16.2%
Effective tax rate
30.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-8.1%
Year over year
Net income growth YoY
-53.6%
Revenue (TTM)
$1.02B
Trailing 12 months
EPS growth YoY
-53.8%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
-1.5%
Revenue CAGR (5Y)
-0.1%
EPS CAGR (3Y)
-25.3%
EPS CAGR (5Y)
-26.4%
FCF CAGR (3Y)
-22.3%
FCF CAGR (5Y)
-16.8%

Quality

14 metrics
Return on equity
—
Return on assets
6.9%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$267.70M
Free cash flow (TTM)
$164.60M
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
4.6
Return on invested capital
24.9%
Trailing 12 months
Net cash
−$1.24B
Latest balance sheet
Cash & equivalents
$214.70M
Total assets
$1.27B
Total debt
$1.46B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$174.10M
Capital expenditures (TTM)
$9.50M
R&D (TTM)
$20.20M
SG&A (TTM)
$319.30M
Stock compensation (TTM)
$25.30M
R&D / revenue
2.0%
Stock compensation / revenue
2.5%

Ownership (13F)

3 metrics
13F filers
322
13F filer change QoQ
-20
Institutional ownership
89.0%

Short interest

3 metrics
Short interest
9.6%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
$557,945
Insider-sentiment score
92 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1872789 CUSIP 29082K105 13F (30d) 174 filings 174 filers Visit website Investor relations